ImmunoCellular Therapeutics to Present at Future Leaders in the Biotech Industry Conference

April 18, 2012

LOS ANGELES, CA – ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company") (OTCBB: IMUC) News), a clinical stage biotechnology company that is focused on developing new immune-based products to treat and diagnose cancer, announced today that Manish Singh, PhD, President and Chief Executive Officer of the Company will be presenting at the 19th Annual Future Leaders in the Biotech Industry Conference in the Millennium Broadway Hotel & Conference Center in New York City. ImmunoCellular will be presenting on Friday, April 20th, 2012 at 2:30 pm EST in presentation room 302/303.

The Annual Future Leaders in the Biotech Industry Conference brings the industry’s top financial professionals together with an agenda designed to meet the current investment climate with an emphasis on fresh investment opportunities. Presenting companies will showcase their innovative science, detail their unpartnered assets and upcoming milestones, offering “the Wall Street community best opportunity to review – in a single day – the leading prospects in the BioCentury.”

The presentation will be webcast following registration at the web address below:
http://www.media-server.com/m/p/kpa55fih

About ImmunoCellular Therapeutics, Ltd.

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently commenced a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. To learn more about IMUC, please visit www.imuc.com.

Contact Information:

ImmunoCellular Therapeutics, Ltd.
CEOcast, Inc.
James Young
Investor Relations
Tel: (212) 732-4300
Email: jyoung@ceocast.com

Source: ImmunoCellular Therapeutics, Ltd.

Download